We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Nanosphere Names Dr. Peter G. Schultz to Board of Directors

Dr. Schultz's widely recognized scientific knowledge will enable him to provide strategic guidance to Nanosphere.
News

Illumina to Develop Genotyping BeadChip

Illumina to collaborate with the WTSI and WT-CCC on the design of a custom Sentrix® BeadChip.
News

DNA Chips Improve Brain Tumour Diagnosis

A team of scientists from the Institut Curie and Inserm have harnessed the technology of DNA chips to distinguish the tumour with the best prognosis.
News

Collaborations to Develop Applications Using HyperSense DNP Technology for NMR

Researchers will use HyperSense™ to identify biological markers for cancer, to develop methods for determining the kinetics and dynamics of protein-ligand interactions and for rapid characterization of compound libraries.
News

Case Western Reserve University Received $5 Million Grant

The grant will support the establishment of the Case Proteomics Center.
News

Sirna Issued UK Patent Covering RNAi-Mediated Inhibition of Gene Expression

The patent broadly covers any siRNA molecule which targets conserved sequences within a virus or a gene.
News

Nucleis will Present its RNAi Technology

Speedy Mouse RNAi Technology is based on targeted transgenesis of short hairpin RNA construct into hprt permissive locus of proprietary ES cells, called BPES cells.
News

Marine Toxins Show Promise as Cancer Drugs

Researchers have determined how this class of toxins interacts with actin, a protein that provides an excellent target for drugs that could inhibit rapid growth of cancer cell.
News

Gene in Mice Controls Risk-Taking Behavior in Humans

Scientists have studied mice with a single copy of the neuroD2 gene and found they had an impaired ability to form emotional memories and conditioned fear.
News

Galapagos and BioFocus Forms Biopharma Outfit

Galapagos hopes that its acquisition of BioFocus will accelerate its transition to a fully integrated drug development biopharmaceutical company.
Advertisement